Review



anti cd27 apc vio770  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Miltenyi Biotec anti cd27 apc vio770
    Anti Cd27 Apc Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd27 apc vio770/product/Miltenyi Biotec
    Average 95 stars, based on 2 article reviews
    anti cd27 apc vio770 - by Bioz Stars, 2026-02
    95/100 stars

    Images



    Similar Products

    anti cd27 apc vio770  (Miltenyi Biotec)
    95
    Miltenyi Biotec anti cd27 apc vio770
    Anti Cd27 Apc Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd27 apc vio770/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    anti cd27 apc vio770 - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    cd27  (Shanghai Korain Biotech Co Ltd)
    93
    Shanghai Korain Biotech Co Ltd cd27
    Cd27, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd27/product/Shanghai Korain Biotech Co Ltd
    Average 93 stars, based on 1 article reviews
    cd27 - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    cd27 apc  (Miltenyi Biotec)
    95
    Miltenyi Biotec cd27 apc
    Cd27 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd27 apc/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    cd27 apc - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    cd27  (Miltenyi Biotec)
    94
    Miltenyi Biotec cd27
    a , RAG1/RAG2 expression in HIV-infected human CD4⁺ T cells following DOS treatment (single dose, 4h), showing rapid induction and complete resolution within 72 hours of treatment. MFI, mean fluorescence intensity (RAG1, n = 6 donors; RAG2, n = 5 donors). In some experiments, the T cells were pre-treated with MG-132 (1mM) prior to DOS treatment ( top right ). b , Reversible DNA-damage signalling assessed by γH2AX foci formation following rejuvenation driven HIV eradication, with resolution over time (96h) and no evidence of persistent genomic stress ( n = 6 donors). c , Stem-like T cell induction among cured T cells (CD4 + CD45RA + <t>CD27</t> + CD28 + CCR7 + , CD62L + , CD95 + ) after a one-week culture and repeated dose treatment throughout (dose escalation). Data are from n = 6 donors. d , Cell viability (Annexin V) show no increase in cell death following DOS exposure, indicating that HIV clearance is not attributable to cytotoxicity or clonal selection ( n = 3 donors). Similar RAG/ γH2AX resolution was observed following repeated (dose escalation) DOS treatment in one-week cultures. In a - d , a paired Student’s t-test. Data are shown as mean ± s.e.m. *** P < 0.001; **** P < 0.0001; ns, not significant.
    Cd27, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd27/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    cd27 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    cd27 pe  (Miltenyi Biotec)
    94
    Miltenyi Biotec cd27 pe
    a , RAG1/RAG2 expression in HIV-infected human CD4⁺ T cells following DOS treatment (single dose, 4h), showing rapid induction and complete resolution within 72 hours of treatment. MFI, mean fluorescence intensity (RAG1, n = 6 donors; RAG2, n = 5 donors). In some experiments, the T cells were pre-treated with MG-132 (1mM) prior to DOS treatment ( top right ). b , Reversible DNA-damage signalling assessed by γH2AX foci formation following rejuvenation driven HIV eradication, with resolution over time (96h) and no evidence of persistent genomic stress ( n = 6 donors). c , Stem-like T cell induction among cured T cells (CD4 + CD45RA + <t>CD27</t> + CD28 + CCR7 + , CD62L + , CD95 + ) after a one-week culture and repeated dose treatment throughout (dose escalation). Data are from n = 6 donors. d , Cell viability (Annexin V) show no increase in cell death following DOS exposure, indicating that HIV clearance is not attributable to cytotoxicity or clonal selection ( n = 3 donors). Similar RAG/ γH2AX resolution was observed following repeated (dose escalation) DOS treatment in one-week cultures. In a - d , a paired Student’s t-test. Data are shown as mean ± s.e.m. *** P < 0.001; **** P < 0.0001; ns, not significant.
    Cd27 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd27 pe/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    cd27 pe - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    phycoerythrin pe rat anti mouse cd27  (Thermo Fisher)
    94
    Thermo Fisher phycoerythrin pe rat anti mouse cd27
    a , RAG1/RAG2 expression in HIV-infected human CD4⁺ T cells following DOS treatment (single dose, 4h), showing rapid induction and complete resolution within 72 hours of treatment. MFI, mean fluorescence intensity (RAG1, n = 6 donors; RAG2, n = 5 donors). In some experiments, the T cells were pre-treated with MG-132 (1mM) prior to DOS treatment ( top right ). b , Reversible DNA-damage signalling assessed by γH2AX foci formation following rejuvenation driven HIV eradication, with resolution over time (96h) and no evidence of persistent genomic stress ( n = 6 donors). c , Stem-like T cell induction among cured T cells (CD4 + CD45RA + <t>CD27</t> + CD28 + CCR7 + , CD62L + , CD95 + ) after a one-week culture and repeated dose treatment throughout (dose escalation). Data are from n = 6 donors. d , Cell viability (Annexin V) show no increase in cell death following DOS exposure, indicating that HIV clearance is not attributable to cytotoxicity or clonal selection ( n = 3 donors). Similar RAG/ γH2AX resolution was observed following repeated (dose escalation) DOS treatment in one-week cultures. In a - d , a paired Student’s t-test. Data are shown as mean ± s.e.m. *** P < 0.001; **** P < 0.0001; ns, not significant.
    Phycoerythrin Pe Rat Anti Mouse Cd27, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phycoerythrin pe rat anti mouse cd27/product/Thermo Fisher
    Average 94 stars, based on 1 article reviews
    phycoerythrin pe rat anti mouse cd27 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    cd27  (Sino Biological)
    94
    Sino Biological cd27
    a , RAG1/RAG2 expression in HIV-infected human CD4⁺ T cells following DOS treatment (single dose, 4h), showing rapid induction and complete resolution within 72 hours of treatment. MFI, mean fluorescence intensity (RAG1, n = 6 donors; RAG2, n = 5 donors). In some experiments, the T cells were pre-treated with MG-132 (1mM) prior to DOS treatment ( top right ). b , Reversible DNA-damage signalling assessed by γH2AX foci formation following rejuvenation driven HIV eradication, with resolution over time (96h) and no evidence of persistent genomic stress ( n = 6 donors). c , Stem-like T cell induction among cured T cells (CD4 + CD45RA + <t>CD27</t> + CD28 + CCR7 + , CD62L + , CD95 + ) after a one-week culture and repeated dose treatment throughout (dose escalation). Data are from n = 6 donors. d , Cell viability (Annexin V) show no increase in cell death following DOS exposure, indicating that HIV clearance is not attributable to cytotoxicity or clonal selection ( n = 3 donors). Similar RAG/ γH2AX resolution was observed following repeated (dose escalation) DOS treatment in one-week cultures. In a - d , a paired Student’s t-test. Data are shown as mean ± s.e.m. *** P < 0.001; **** P < 0.0001; ns, not significant.
    Cd27, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd27/product/Sino Biological
    Average 94 stars, based on 1 article reviews
    cd27 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    a , RAG1/RAG2 expression in HIV-infected human CD4⁺ T cells following DOS treatment (single dose, 4h), showing rapid induction and complete resolution within 72 hours of treatment. MFI, mean fluorescence intensity (RAG1, n = 6 donors; RAG2, n = 5 donors). In some experiments, the T cells were pre-treated with MG-132 (1mM) prior to DOS treatment ( top right ). b , Reversible DNA-damage signalling assessed by γH2AX foci formation following rejuvenation driven HIV eradication, with resolution over time (96h) and no evidence of persistent genomic stress ( n = 6 donors). c , Stem-like T cell induction among cured T cells (CD4 + CD45RA + CD27 + CD28 + CCR7 + , CD62L + , CD95 + ) after a one-week culture and repeated dose treatment throughout (dose escalation). Data are from n = 6 donors. d , Cell viability (Annexin V) show no increase in cell death following DOS exposure, indicating that HIV clearance is not attributable to cytotoxicity or clonal selection ( n = 3 donors). Similar RAG/ γH2AX resolution was observed following repeated (dose escalation) DOS treatment in one-week cultures. In a - d , a paired Student’s t-test. Data are shown as mean ± s.e.m. *** P < 0.001; **** P < 0.0001; ns, not significant.

    Journal: bioRxiv

    Article Title: Awakening intracellular immunity for functional HIV cure

    doi: 10.64898/2026.01.04.697570

    Figure Lengend Snippet: a , RAG1/RAG2 expression in HIV-infected human CD4⁺ T cells following DOS treatment (single dose, 4h), showing rapid induction and complete resolution within 72 hours of treatment. MFI, mean fluorescence intensity (RAG1, n = 6 donors; RAG2, n = 5 donors). In some experiments, the T cells were pre-treated with MG-132 (1mM) prior to DOS treatment ( top right ). b , Reversible DNA-damage signalling assessed by γH2AX foci formation following rejuvenation driven HIV eradication, with resolution over time (96h) and no evidence of persistent genomic stress ( n = 6 donors). c , Stem-like T cell induction among cured T cells (CD4 + CD45RA + CD27 + CD28 + CCR7 + , CD62L + , CD95 + ) after a one-week culture and repeated dose treatment throughout (dose escalation). Data are from n = 6 donors. d , Cell viability (Annexin V) show no increase in cell death following DOS exposure, indicating that HIV clearance is not attributable to cytotoxicity or clonal selection ( n = 3 donors). Similar RAG/ γH2AX resolution was observed following repeated (dose escalation) DOS treatment in one-week cultures. In a - d , a paired Student’s t-test. Data are shown as mean ± s.e.m. *** P < 0.001; **** P < 0.0001; ns, not significant.

    Article Snippet: In some experiments, cells were evaluated for H2AX (Cell Signaling, 2595S; 1:100) and stem like reprogramming with antibodies to CD4 (PerCP5.5, BioLegend, 557956; 1:100), CCR7 (Brillant Violet 421, Biolegend, 100540; 1:100); CD27 (PerCP-Vio 700, Miltenyi; 130-120-037; 1:100); CD28 (PerCP/Cy5.5, BioLegend, 302922; 1:100); CD45RA (BV510, BioLegend, 304142; 1:100); CD62L (PE-Vio 770; Miltenyi; 130-113-621; 1:100) and CD95 (FITC, Miltenyi, 130-122-950; 1:100).

    Techniques: Expressing, Infection, Fluorescence, Selection